Literature DB >> 7688507

Characterization of HIV-1 reverse transcriptase with antibodies indicates conformational differences between the RNAse H domains of p 66 and p 15.

A M Szilvay1, S Nornes, A Kannapiran, B I Haukanes, C Endresen, D E Helland.   

Abstract

Antibody binding to the p 66 and p 15 RNase H regions of HIV-1 reverse transcriptase was compared using a polyclonal rabbit immune serum raised against a synthetic peptide from the RNase H region of reverse transcriptase (aa 511-527) and six monoclonal antibodies binding to discontinuous epitopes in the RNase H region of p 66. The antigens used in Western blot analysis included recombinantly expressed homodimeric p 66 digested with the HIV-1 protease for generation of the p 51 and p 15 polypeptides and two different length RNase H domains expressed as Trp E fusion proteins (aa 410-560 and aa 441-560). The polyclonal rabbit antibody binding to a continuous epitope recognized both the Trp E-fusion proteins and also the polypeptides p 66 and p 15 generated by processing of homodimeric p 66 with the viral protease. Two additional cleavage products with estimated molecular weights of 9 and 11 kDa were also detected. The anti-RNase H MAbs binding to discontinuous epitopes recognized only the RNase H domain of the p 66 polypeptide and the Trp E-RNase H fusion protein when this was expressed together with the C-terminal part of the polymerase domain. The results indicate conformational differences between the RNase H domain of the p 66 subunit and the RNase H p 15 polypeptide.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688507     DOI: 10.1007/bf01378640

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  30 in total

1.  Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1.

Authors:  P L Boyer; A L Ferris; S H Hughes
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

2.  Purification and characterization of the RNase H domain of HIV-1 reverse transcriptase expressed in recombinant Escherichia coli.

Authors:  S P Becerra; G M Clore; A M Gronenborn; A R Karlström; S J Stahl; S H Wilson; P T Wingfield
Journal:  FEBS Lett       Date:  1990-09-17       Impact factor: 4.124

3.  Linker insertion mutagenesis of the human immunodeficiency virus reverse transcriptase expressed in bacteria: definition of the minimal polymerase domain.

Authors:  V R Prasad; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  Recombinant polypeptides from the human immunodeficiency virus reverse transcriptase define three epitopes recognized by antibodies in sera from patients with acquired immunodeficiency syndrome.

Authors:  C Padberg; S Nowlan; B Mermer
Journal:  AIDS Res Hum Retroviruses       Date:  1989-02       Impact factor: 2.205

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor.

Authors:  C Debouck; J G Gorniak; J E Strickler; T D Meek; B W Metcalf; M Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  Mutational analysis of the ribonuclease H activity of human immunodeficiency virus 1 reverse transcriptase.

Authors:  A Hizi; S H Hughes; M Shaharabany
Journal:  Virology       Date:  1990-04       Impact factor: 3.616

8.  Reconstitution in vitro of RNase H activity by using purified N-terminal and C-terminal domains of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  Z Hostomsky; Z Hostomska; G O Hudson; E W Moomaw; B R Nodes
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

9.  Purification and characterization of heterodimeric human immunodeficiency virus type 1 (HIV-1) reverse transcriptase produced by in vitro processing of p66 with recombinant HIV-1 protease.

Authors:  D Chattopadhyay; D B Evans; M R Deibel; A F Vosters; F M Eckenrode; H M Einspahr; J O Hui; A G Tomasselli; H A Zurcher-Neely; R L Heinrikson
Journal:  J Biol Chem       Date:  1992-07-15       Impact factor: 5.157

10.  Processing protease and reverse transcriptase from human immunodeficiency virus type I polyprotein in Escherichia coli.

Authors:  J Mous; E P Heimer; S F Le Grice
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

View more
  1 in total

1.  The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles.

Authors:  Guney Boso; Claes Örvell; Nikunj V Somia
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.